0001209191-17-013940.txt : 20170223
0001209191-17-013940.hdr.sgml : 20170223
20170223173810
ACCESSION NUMBER: 0001209191-17-013940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170221
FILED AS OF DATE: 20170223
DATE AS OF CHANGE: 20170223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 750
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Went Gregory T
CENTRAL INDEX KEY: 0001604541
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 17633889
MAIL ADDRESS:
STREET 1: C/O ADAMAS PHARMACEUTICALS, INC.
STREET 2: 2200 POWELL ST, STE 220
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-21
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001604541
Went Gregory T
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 750
EMERYVILLE
CA
94608
1
1
0
0
Chief Executive Officer
Common Stock
2017-02-21
4
A
0
23125
0.00
A
169333
D
Common Stock
195392
I
By Trust
Common Stock
80000
I
Gregory T. Went & Marjorie S. Went ttees 2012 Irr Trust FBO Bridget Elise Went
Common Stock
80000
I
Gregory T. Went & Marjorie S. Went ttees 2012 Irr Trust FBO Cora Margaret Went
Stock Option (Right to Buy)
17.20
2017-02-21
4
A
0
138750
0.00
A
2027-02-20
Common Stock
138750
138750
D
The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2018, March 20, 2019, March 20, 2020 and March 20, 2021, subject to Reporting Person's Continuous Service as of each such date.
The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2017, subject to Reporting Person's Continuous Service as of each such date.
/s/Jennifer Rhodes, as Attorney-in-Fact
2017-02-23